Skip to content

Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot Study

Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04722198
Enrollment
20
Registered
2021-01-25
Start date
2020-10-27
Completion date
2021-12-31
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Onset Parkinson Disease

Brief summary

This study is designed to examine L. plantarum PS128 can improve symptoms in early onset PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with early onset PD will receive PS128 treatment for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.

Interventions

DIETARY_SUPPLEMENTPS128

daily ingestion 2 capsules of Lactobacillus plantarum PS128 (\>10 billion CFU/capsule)

Sponsors

Professor Lu Neurological Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Early Onset Parkinson's Disease, EOPD * at least 9 years education * age between 20 and 80 years old

Exclusion criteria

* Patients on antibiotics within the preceding one month * Patients using of other probiotic products (sachet, capsule or tablet) within the preceding two weeks * Have undergone surgery of liver, bladder, or gastrointestinal tract * Have current or history of inflammatory bowel disease * Have history of cancer * Known allergy to probiotics * Patients with comorbid dementia (Mini-Mental State Examination score ≤ 26) or major depression (The Beck Depression Inventory-II score ≥ 29) * Have received deep brain stimulation * Patients receiving artificial enteral or intravenous nutrition * Diagnosed before 40 years old * Poor control of other chronic diseases * Not eligible judged by PI

Design outcomes

Primary

MeasureTime frameDescription
UPDRS III12 weeksThe UPDRS scale refers to Unified Parkinson Disease Rating Scale, and it is a rating tool used to gauge the course of Parkinson's disease in patients. The PART III is Motor sections.
MHY12 weeksThe Hoehn and Yahr scale is a commonly used system for describing how the symptoms of Parkinson's disease progress. The modified Hoehn and Yahr scale included stages 1 through 5. to help describe the intermediate course of the disease.
TUG12 weeksObserve the patient's postural stability, gait, stride length, sway and test cut-off times.

Secondary

MeasureTime frameDescription
VAS-GIBaseline and Post-12 weeksVisual Analogue Scale (VAS) consists of a line, 10 cm in length. Individuals point to or mark a spot on the line where they feel indicates their current their emotion, fatigue level and sleep quality. The score of emotion level is from 0cm (very nervous) to 10 cm (very relaxing). The score of fatigue level is from 0 cm (very energetic) to 10 cm (very sleepy). The score of sleep quality is from 0 cm (poor) to 10 cm (sleep well). The maximum total score is 100% (equal 10cm).
UPDRS I-IVBaseline and Post-12 weeksThe UPDRS scale refers to Unified Parkinson Disease Rating Scale, and it is a rating tool used to gauge the course of Parkinson's disease in patients. The UPDRS scale consists of the following five segments: 1) Mentation, Behavior, and Mood, 2) ADL, 3) Motor sections, 4) Modified Hoehn and Yahr Scale, and 5) Schwab and England ADL scale.
PGICPost-12 weeksThe self-report measure Patient Global Impression of Change (PGIC) reflects a patient's belief about the efficacy of treatment. PGIC is a 7 point scale depicting a patient's rating of overall improvement. Patients rate their change as very much improved, much improved, minimally improved, no change, minimally worse, much worse, or very much worse.
SCL-90-RBaseline and Post-12 weeksThe Symptom Checklist-90-Revised instrument helps evaluate a broad range of psychological problems and symptoms of psychopathology. The SCL-90-R is normed on individuals 13 years and older. It consists of 90 items and takes 12-15 minutes to administer.
CPSQIBaseline and Post-12 weeksThe Chinese Version of the Pittsburgh Sleep Quality Index is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score, and takes 5-10 minutes to complete.The maximum total score is 21. A higher score reflects more poor sleep quality.

Countries

Taiwan

Contacts

Primary ContactChin-Song Lu, MD
cslu.public@gmail.com886-3-3960388

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026